Chronic liver diseases such as hepatitis, liver cirrhosis, and hepatocellular carcinoma are a major cause of morbidity and mortality worldwide. Fibrosis—the thickening and scarring of connective ...
Please provide your email address to receive an email when new articles are posted on . Treatment responders demonstrated significant reductions in iron corrected T1 and liver fat content. Optimal ...
E-Scopics, a pioneer in advanced point-of-care liver imaging, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its new Hepatoscope-Derived Fat Fraction ...
Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through ...
WASHINGTON & OXFORD, England--(BUSINESS WIRE)--Perspectum announced two research studies that were recently published, bringing hope to people with metabolic dysfunction-associated steatohepatitis ...
ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for the ...
Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...
Add Yahoo as a preferred source to see more of our stories on Google. We spoke with three major companies that offer such testing – Function (which recently acquired Ezra), Prenuvo and SimonMed – and ...
MALMÖ, SE / ACCESS Newswire / June 9, 2026 / Ascelia Pharma AB (publ)(STO:ACE) announces that Orviglance® data will be presented as an oral presentation today at the European Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results